A cost-effective moderate-intensity interdisciplinary weight-management programme for individuals with prediabetes

Diabetes and Metabolism

Volumn 37, Issue 5, 2011, Pages 410-418

  Gagnon, C ^a   Brown, C ^a   Couture, C ^a   Kamga Ngande, C N ^a   Hivert, M F ^a   Baillargeon, J P ^a   Carpentier, A C ^a   Langlois, M F ^a  

^a Centre Hospitalier Universitaire de Sherbrooke   (Canada)

Author keywords

Diabetes; Glucose intolerance; Interdisciplinary programme; Obesity; Weight loss

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; COST EFFECTIVENESS ANALYSIS; EXERCISE INTENSITY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH PROGRAM; HIGH RISK PATIENT; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE MODIFICATION; LIPID BLOOD LEVEL; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT COUNSELING; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADULT; AGED; COST-BENEFIT ANALYSIS; COUNSELING; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; HUMANS; MALE; MIDDLE AGED; OBESITY; PATIENT CARE TEAM; PREDIABETIC STATE; PROGRAM EVALUATION; RISK FACTORS; RISK REDUCTION BEHAVIOR; TREATMENT OUTCOME; WAIST CIRCUMFERENCE; WEIGHT LOSS;

EID: 81055157146     PISSN: 12623636     EISSN: 18781780     Source Type: Journal    
DOI: 10.1016/j.diabet.2011.01.003     Document Type: Article

References (27)

1. Lipscombe L.L., Hux J.E. Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study. Lancet 2007, 369:750-756.
2. Knowler W.C., Barrett-Connor E., Fowler S.E., Hamman R.F., Lachin J.M., Walker E.A., et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393-403.
3. Tuomilehto J., Lindstrom J., Eriksson J.G., Valle T.T., Hamalainen H., Ilanne-Parikka P., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344:1343-1350.
4. Pan X.R., Li G.W., Hu Y.H., Wang J.X., Yang W.Y., An Z.X., et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997, 20:537-544.
5. Kamga-Ngande C.N.C.A., Nadeau-Marcotte F., Ardilouze J.L., Baillargeon J.P., Bellabarba D., Houde G., et al. Effectiveness of a multidisciplinary program for management of morbid obesity: the Unité d'enseignement, de traitement et de recherche sur l'obésité (UETRO) database study. Metab Syndr Relat Disord 2009, 7:297-304.
6. Canada Fitness Survey, Fitness and Lifestyle in Canada: Ottawa, 1983.
7. Thomson R., Brinkworth G.D., Buckley J.D., Noakes M., Clifton P.M. Good agreement between bioelectrical impedance and dual-energy X-ray absorptiometry for estimating changes in body composition during weight loss in overweight young women. Clin Nutr 2007, 26:771-777.
8. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-7.
9. Bériault KCA, Gagnon C, Ménard J, Baillargeon JP, Ardilouze JL, Langlois MF. Reproducibility of the 6-minute walk test in overweight and obese adults. Int J Sports Med 2009;30:725-7.
10. Schutz Y., Weinsier S., Terrier P., Durrer D. A new accelerometric method to assess the daily walking practice. Int J Obes Relat Metab Disord 2002, 26:111-118.
11. Carpentier A.C., Frisch F., Cyr D., Genereux P., Patterson B.W., Giguere R., et al. On the suppression of plasma non esterified fatty acids by insulin during enhanced intravascular lipolysis in humans. Am J Physiol Endocrinol Metab 2005, 289:E849-E856.
12. Breda E., Cavaghan M.K., Toffolo G., Polonsky K.S., Cobelli C. Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity. Diabetes 2001, 50:150-158.
13. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
14. Utzschneider K.M., Prigeon R.L., Faulenbach M.V., Tong J., Carr D.B., Boyko E.J., et al. Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-hour glucose levels. Diabetes Care 2009, 32:335-341.
15. Venditti E.M., Bray G.A., Carrion-Petersen M.L., Delahanty L.M., Edelstein S.L., Hamman R.F., et al. First versus repeat treatment with a lifestyle intervention program: attendance and weight loss outcomes. Int J Obes (Lond) 2008, 32:1537-1544.
16. Laatikainen T., Dunbar J.A., Chapman A., Kilkkinen A., Vartiainen E., Heistaro S., et al. Prevention of type 2 diabetes by lifestyle intervention in an Australian primary health care setting: greater Green Triangle (GGT) Diabetes Prevention Project. BMC Public Health 2007, 7:249.
17. Kong W., Langlois M.F., Kamga-Ngande C., Gagnon C., Brown C., Baillargeon J.P. Predictors of success to weight-loss intervention program in individuals at high risk for type 2 diabetes. Diabetes Res Clin Pract 2010, 90:147-153.
18. Wolf A.M., Conaway M.R., Crowther J.Q., Hazen K.Y., J L.N., Oneida B., et al. Translating lifestyle intervention to practice in obese patients with type 2 diabetes: improving control with activity and nutrition (ICAN) study. Diabetes Care 2004, 27:1570-1576.
19. Oldroyd J.C., Unwin N.C., White M., Mathers J.C., Alberti K.G. Randomised controlled trial evaluating lifestyle interventions in people with impaired glucose tolerance. Diabetes Res Clin Pract 2006, 72:117-127.
20. de Koning L., Merchant A.T., Pogue J., Anand S.S. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J 2007, 28:850-856.
21. Zhang C., Rexrode K.M., van Dam R.M., Li T.Y., Hu F.B. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: 16 years of follow-up in US women. Circulation 2008, 117:1658-1667.
22. Hernan W.H., Brandle M., Zhang P., Williamson D.F., Matulik M.J., Ratner R.E., et al. Costs associated with the primary prevention of type 2 diabetes mellitus in the diabetes prevention program. Diabetes Care 2003, 26:36-47.
23. Jakicic J.M., Marcus B.H., Lang W., Janney C. Effect of exercise on 24-month weight loss maintenance in overweight women. Arch Intern Med 2008, 168:1550-1559. [discussion 1559-60].
24. Chomentowski P., Dube J.J., Amati F., Stefanovic-Racic M., Zhu S., Toledo F.G., et al. Moderate exercise attenuates the loss of skeletal muscle mass that occurs with intentional caloric restriction-induced weight loss in older, overweight to obese adults. J Gerontol A Biol Sci Med Sci 2009, 64:575-580.
25. Hunter G.R., Byrne N.M., Sirikul B., Fernandez J.R., Zuckerman P.A., Darnell B.E., et al. Resistance training conserves fat-free mass and resting energy expenditure following weight loss. Obesity (Silver Spring) 2008, 16:1045-1051.
26. Silverman N.E., Nicklas B.J., Ryan A.S. Addition of aerobic exercise to a weight loss program increases BMD, with an associated reduction in inflammation in overweight post-menopausal women. Calcif Tissue Int 2009, 84:257-265.
27. Lindstrom J., Ilanne-Parikka P., Peltonen M., Aunola S., Eriksson J.G., Hemio K., et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006, 368:1673-1679.